The diagnostic process typically involves: Clinical history taking, focusing on symptoms (fatigue, neurological changes, dietary habits) Physical examination for signs of anaemia or neurological impairment Blood tests including full blood count, serum B12, and often folate levels Additional investigations such as intrinsic factor antibodies or parietal cell antibodies if pernicious anaemia is suspected For borderline results, additional tests like holotranscobalamin (active B12) may be considered NICE guidance recommends that treatment should commence based on clinical presentation if neurological symptoms are present, without waiting for laboratory confirmation, as delays can result in irreversible nerve damage

Alluvi Healthcare BPC 157 Premium UK Recovery & Repair Peptide Alluvi Healthcare BPC 157 is the most comprehensive recovery peptide uk product in the alluvi healthcare peptides range a precision-formulated bpc 157 tb500 uk blend delivering BPC-157 and TB500 in a single pre-filled pen at 40mg total, providing 4 doses of 10mg
Nasal sprays are less invasive than injections and therefore more suited to regular use
Your healthcare provider will determine safe combinations
Naviaux et al., 2019
In mouse sepsis and endotoxemia, trimetazidine (60 mg/kg) promoted neutrophil recruitment to the heart tissue and alleviated myocardial dysfunction [152]